Loading clinical trials...
Loading clinical trials...
This study investigates the efficacy of probiotic VSL#3 as an add on standard care on the activity of the disease in patients with Juvenile Idiopathic Arthritis.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
NCT06838143 · Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), and more
NCT06870045 · Juvenile Idiopathic Arthritis, Childhood Rheumatic Disease
NCT05534347 · Juvenile Idiopathic Arthritis (JIA)
NCT04902807 · Autoimmune Lymphoproliferative Syndrome, Autoimmune Cytopenia, and more
NCT04833465 · Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus, and more
Robert Debre Hospital
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions